Top Markets
#1 Seeker Seeker +118.45%
#2 AI XOVIA AI XOVIA +109.92%
#3 MowCat MowCat +107.21%
#4 Helium Helium +79.69%
#5 Pons Pons +48.98%
#6 UnifAI Network UnifAI Network +38.31%
#7 Zora Zora +33.18%
#8 Zylo Ecosystem Zylo Ecosystem +20.99%
#9 Bounce Bounce +20.57%
#10 Tensor Tensor +17.68%
Coin of the day
Seeker Seeker
Settings
Language
ENGLISH
Currency
USD
Theme
Clarity Pharmaceuticals Ltd Clarity Pharmaceuticals Ltd

Clarity Pharmaceuticals Ltd

CU6
Rank in Stocks #11775
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company,... Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company’s lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.
Share Price
$1.77
Last synced: 2026-08-28
Market Cap
$660.45M
Change (1 day)
7.26%
Change (1 year)
-9.15%
Country
AU
Trade Clarity Pharmaceuticals Ltd (CU6)

Category

Healthcare
Revenue for Clarity Pharmaceuticals Ltd (CU6)
Revenue in Aug 2026 TTM: 0
According to Clarity Pharmaceuticals Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Clarity Pharmaceuticals Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
STERIS plc STERIS plc
STERIS plc
STE.US
 $6.04B -
IE
Shanghai United Imaging Healthcare Co., Ltd. Shanghai United Imaging Healthcare Co., Ltd.
Shanghai United Imaging Healthcare Co., Ltd.
688271.SS
 - -
CN
Ypsomed Holding AG Ypsomed Holding AG
Ypsomed Holding AG
YPSN.SW
 - -
CH
Medacta Group S.A. Medacta Group S.A.
Medacta Group S.A.
MOVE.SW
 - -
CH
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.
Jafron Biomedical Co.,Ltd.
300529.SZ
 - -
CN